#USA #Mumbai #Piramal Critical Care #Blue-Zone Technologies #Anesthesia Gas

Piramal Critical Care and Blue-Zone Technologies Partner for Anesthesia Gas Recovery

In a significant move towards sustainability in healthcare, Piramal Critical Care, Inc. (PCC), a subsidiary of Piramal Pharma Limited, has collaborated with Blue-Zone Technologies Ltd. to develop advanced technologies for the capture, collection, and recycling of waste anesthesia gases. This innovative partnership aims to minimize the environmental impact of volatile anesthetics utilized in medical settings.

The Collaboration Overview

The partnership integrates Blue-Zone's cutting-edge technology for capturing and purifying surplus anesthesia gases with the extensive production and marketing capabilities of Piramal. This initiative not only addresses ecological concerns but also ensures that the essential product, inhalation anesthetics, remains a primary method for providing general anesthesia worldwide.

Pending regulatory approval for the Phoenix Deltasorb® system in Europe, Blue-Zone plans to offer its gas capture systems to PCC customers initially in France and Germany. Blue-Zone will oversee all activities related to the installation and operation of its systems within healthcare facilities, while PCC will utilize the extracted anesthetic gases through Blue-Zone’s technology to produce Sevofluran USP, approved for human use in Canada.

Both companies expect to expand the capture and recycling of surplus anesthetic gases and the marketing of Sevofluran USP derived from extracted gases to additional regions in the future.

Comments from Leadership

Jeff Hampton, the President and COO of Piramal Critical Care, expressed pride in this collaboration, highlighting the importance of reducing waste and environmental burden caused by anesthetic gases. He stated, “Through the introduction of gas capture technology, hospitals can select the inhalation anesthetic that best meets clinical demands while aiding sustainable healthcare objectives.”

Inhalation anesthetics are vital medications that provide necessary treatments to patients worldwide. Piramal Pharma, as a leading manufacturer in general anesthesia products, is dedicated to supporting healthcare professionals, hospitals, and systems with solutions that balance clinical performance with environmental responsibility. The ultimate goal is to ensure patients receive essential care while promoting more sustainable approaches to anesthesia.

About Piramal Critical Care

PCC has positioned itself as a global leader in the fields of anesthesia, pain management, and intrathecal therapies. With a presence in over 100 countries, the company offers a wide portfolio that includes inhalation anesthetics, intrathecal treatments, plasma volume expanders, and various injectable drugs and generics. PCC boasts robust production and process development capabilities with modern facilities compliant with strict GMP regulations in Bethlehem, Pennsylvania, and in Digwal and Dahej, India.

Furthermore, PCC collaborates with leading pharmaceutical development and manufacturing enterprises across the globe, working together to enhance product offerings and ensure quality compliance.

About Piramal Pharma Ltd

Piramal Pharma Limited (PPL) provides a diverse portfolio of products and services through its 17 global development and manufacturing sites, along with a distribution network in over 100 countries. Incorporating divisions such as Piramal Pharma Solutions (PPS) and the hospital-focused PCC, PPL is also engaged in consumer healthcare, offering over-the-counter products. The joint venture with Abbvie Therapeutics India Private Limited has established itself as a leader in ophthalmology within the Indian pharmaceutical market. PPL has also taken a strategic minority stake in Yapan Bio Private Limited, focusing on biologics, biotherapeutics, and vaccines.

For more information about Piramal Pharma, visit Piramal Pharma | LinkedIn.

About Blue-Zone Technologies Ltd

Based in Ontario, Canada, Blue-Zone is an innovative cleantech pharmaceutical company dedicated to the capture and recycling of waste anesthetic gases (WAG). With the mission to protect the environment and produce volatile anesthetics responsibly, Blue-Zone collaborates with strategic investors and partners around the globe to develop technologies that support the entire lifecycle of volatile anesthetics. The company emphasizes the importance of capturing WAG in healthcare facilities using volatile anesthetics and converting them into approved anesthetic products.

For further inquiries about Blue-Zone, visit www.blue-zone.com.